{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:54:44Z","timestamp":1791298484691,"version":"4.1.0"},"reference-count":37,"publisher":"Wiley","issue":"17","license":[{"start":{"date-parts":[[2006,8,17]],"date-time":"2006-08-17T00:00:00Z","timestamp":1155772800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The FEBS Journal"],"published-print":{"date-parts":[[2006,9]]},"abstract":"<jats:p>Gaucher disease is an autosomal recessive lysosomal storage disorder caused by the deficient activity of glucocerebrosidase. Accumulation of glucosylceramide, primarily in the lysosomes of cells of the reticuloendothelial system, leads to hepatosplenomegaly, anemia and skeletal lesions in type I disease, and neurologic manifestations in types II and III disease. We report herein the identification of hydrophilic active\u2010site\u2010specific chaperones that are capable of increasing glucocerebrosidase activity in the cultured fibroblasts of Gaucher patients. Screening of a variety of natural and synthetic alkaloid compounds showed isofagomine, <jats:italic>N<\/jats:italic>\u2010dodecyl deoxynojirimycin, calystegines A<jats:sub>3<\/jats:sub>, B<jats:sub>1<\/jats:sub>, B<jats:sub>2<\/jats:sub> and C<jats:sub>1<\/jats:sub>, and 1,5\u2010dideoxy\u20101,5\u2010iminoxylitol to be potent inhibitors of glucocerebrosidase. Among them, isofagomine was the most potent inhibitor of glucocerebrosidase <jats:italic>in vitro<\/jats:italic>, and the most effective active\u2010site\u2010specific chaperone capable of increasing residual glucocerebrosidase activity in fibroblasts established from Gaucher patients with the most prevalent Gaucher disease\u2010causing mutation (N370S). Intracellular enzyme activity increased approximately two\u2010fold after cells had been incubated with isofagomine, and the increase in glucocerebrosidase activity was both dose\u2010dependent and time\u2010dependent. Western blotting demonstrated that there was a substantial increase in glucocerebrosidase protein in cells after isofagomine treatment. Immunocytochemistry revealed an improvement in the glucocerebrosidase trafficking pattern, which overlaps that of lysosome\u2010associated membrane protein 2 in Gaucher fibroblasts cultivated with isofagomine, suggesting that the transport of mutant glucocerebrosidase is at least partially improved in the presence of isofagomine. The hydrophilic active\u2010site\u2010specific chaperones are less toxic to cultured cells. These results indicate that these hydrophilic small molecules are suitable candidates for further drug development for the treatment of Gaucher disease.<\/jats:p>","DOI":"10.1111\/j.1742-4658.2006.05410.x","type":"journal-article","created":{"date-parts":[[2006,8,17]],"date-time":"2006-08-17T15:17:17Z","timestamp":1155827837000},"page":"4082-4092","source":"Crossref","is-referenced-by-count":117,"title":["Hydrophilic iminosugar active\u2010site\u2010specific chaperones increase residual glucocerebrosidase activity in fibroblasts from Gaucher patients"],"prefix":"10.1111","volume":"273","author":[{"given":"Hui\u2010Hwa","family":"Chang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Asano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshitaka","family":"Ichikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian\u2010Qiang","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2006,8,17]]},"reference":[{"key":"e_1_2_6_2_2","first-page":"3635","volume-title":"The Metabolic and Molecular Bases of Inherited Disease","author":"Beutler E","year":"2001"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-291X(65)90743-6"},{"key":"e_1_2_6_4_2","volume-title":"Gaucher Disease: Enzymology, Genetics, and Treatment","author":"Grabowski GA","year":"1993"},{"key":"e_1_2_6_5_2","first-page":"258","article-title":"Enzyme replacement therapy in type I Gaucher disease","volume":"104","author":"Kay AC","year":"1991","journal-title":"Trans Assoc Am Phys"},{"key":"e_1_2_6_6_2","first-page":"139A","article-title":"Safety and efficacy of macrophage targeted recombinant glucocerebrosidase therapy","volume":"33","author":"Grabowski GA","year":"1993","journal-title":"Pediatr Res"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-2952(98)00115-4"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)02161-9"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1025902113005"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.embor.embor873"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(17)42166-1"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199812033392307"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature02265"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1038\/ncb0805-766"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.biocel.2005.05.008"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1038\/4801"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-6147(03)00158-5"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.192582899"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2004.03.007"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.chembiol.2005.09.007"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1432-1327.2000.01457.x"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0076-6879(03)01069-3"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1002\/anie.200502662"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1093\/glycob\/10.11.1217"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1021\/ja973443k"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.2165\/00128072-200204070-00001"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcmd.2005.05.007"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2536657100"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M308523200"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0404764101"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0854.2004.00232.x"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tem.2004.05.003"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1432-1033.1997.00296.x"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0031-9422(99)00555-5"},{"key":"e_1_2_6_35_2","doi-asserted-by":"publisher","DOI":"10.1021\/jf010567e"},{"key":"e_1_2_6_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0957-4166(02)00799-1"},{"key":"e_1_2_6_37_2","doi-asserted-by":"publisher","DOI":"10.1021\/jm00013a012"},{"key":"e_1_2_6_38_2","doi-asserted-by":"publisher","DOI":"10.1006\/abbi.2000.1743"}],"container-title":["The FEBS Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1742-4658.2006.05410.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/febs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1742-4658.2006.05410.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T08:51:37Z","timestamp":1697446297000},"score":1,"resource":{"primary":{"URL":"https:\/\/febs.onlinelibrary.wiley.com\/doi\/10.1111\/j.1742-4658.2006.05410.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,8,17]]},"references-count":37,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2006,9]]}},"alternative-id":["10.1111\/j.1742-4658.2006.05410.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1742-4658.2006.05410.x","archive":["Portico"],"relation":{},"ISSN":["1742-464X","1742-4658"],"issn-type":[{"value":"1742-464X","type":"print"},{"value":"1742-4658","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,8,17]]}}}